One hundred and eight women were assessed, and eight women were excluded from the study, according to the exclusion criteria. Thus, a total of 100 patients were enrolled in this clinical trial (figure ...

Learn everything you need to know about Granisetron-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. In a double-blind, randomized, stratified, parallel-group study, the efficacy and safety of granisetron and ...

Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma. Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as ...

Active ingredient: Granisetron 3.1 mg/24 hours; transdermal delivery system (patch). Indication: Prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic ...

Granisetron (Grandem (5 ml)) is an antiemetic, prescribed for nausea and vomiting associated with chemotherapy drugs. It blocks a chemical named as serotonin that can cause vomiting. The information ...

Boston, MA, USA: New data presented today to international delegates attending the 14th Annual Meeting of the Multinational Association of Supportive Cancer Care (MASCC), showed that Kytril® ...

Chemotherapy: give only on the days chemotherapy is given. 2mg up to 1 hour before chemotherapy; or, 1mg up to 1 hour before chemotherapy, then 1mg 12 hours after initial dose. Radiation: 2mg within 1 ...

Granisetron (as HCl) 1mg/mL (contains benzyl alcohol); 0.1mg/mL (preservative-free); IV inj. Chemotherapy: give as an undiluted IV injection over 30 seconds or as a diluted IV infusion over 5 minutes.

Background: Women undergoing general anaesthesia for breast surgery are especially at risk of experiencing postoperative nausea and vomiting (PONV). This study was undertaken to assess the efficacy of ...